Table 9. Biofilm inhibition and dispersal by co-application of tobramycin or G3KL with FD2.
| Compound | Antimicrobial compound | MBIC [μM] | Dispersal a [μM] |
| FD2 | — | 20 | 50 |
| FD2 | Tobramycin 0.1 μM | 5 | 10 |
| FucC6G2 | — | 9 | 30 |
| FucC6G2 | Tobramycin 0.1 μM | 9 | 20 |
| FD2 | G3KL 1.2 μM | 5 | 20 |
| FD2 | G3KL 0.1 μM | 10 | 20 |
aConcentration necessary to disperse 100% of the biofilm, see also legend of Fig. 2.